IL6R and type 1 diabetes mellitus: Interestingly, a recent integrative analysis of genetic association, functional genomics data and protein–protein networks identified DGKQ as a potential novel type 1 diabetes therapeutic gene target along with other novel and known targets, e.g., IL2RA, IL6ST, IL6R and TYK2 [3].